WallStreetZenWallStreetZen

NASDAQ: CFRX
Contrafect Corp Stock

Buy CFRX
$0.28-0.01 (-3.45%)
Updated Aug 9, 2022
CFRX Price
$0.28
Fair Value Price
N/A
Market Cap
$11.01M
52 Week Low
$0.28
52 Week High
$4.54
P/E
-0.31x
P/B
0.37x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$35.24M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.87
Operating Cash Flow
-$44M
Beta
0.98
Next Earnings
Aug 11, 2022
Ex-Dividend
N/A
Next Dividend
N/A

CFRX Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CFRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CFRX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CFRX is good value based on its book value relative to its share price (0.37x), compared to the US Biotechnology industry average (4.77x)
P/B vs Industry Valuation
CFRX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CFRX due diligence checks available for Premium users.

CFRX News

Valuation

CFRX fair value

Fair Value of CFRX stock based on Discounted Cash Flow (DCF)
Price
$0.28
Fair Value
$0.55
Undervalued by
49.37%
CFRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CFRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.31x
Industry
-5.67x
Market
32.55x

CFRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.37x
Industry
4.77x
CFRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CFRX's financial health

Profit margin

Revenue
$0.0
Net Income
-$20.2M
Profit Margin
0%
CFRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$56.0M
Liabilities
$26.0M
Debt to equity
0.87
CFRX's short-term assets ($52.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CFRX's short-term assets ($52.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CFRX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CFRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.8M
Investing
$4.8M
Financing
$0.0
CFRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CFRX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CFRX$11.01M-2.78%-0.31x0.37x
PTIX$11.13M0.00%-2.22x1.28x
AYTU$10.84M-51.72%-0.07x0.18x
GLMD$10.76M-4.88%-0.43x0.52x
PSTV$11.27M-3.85%-0.51x1.16x

Contrafect Stock FAQ

What is Contrafect's quote symbol?

NASDAQ: CFRX) Contrafect trades on the NASDAQ under the ticker symbol CFRX. Contrafect stock quotes can also be displayed as NASDAQ: CFRX.

If you're new to stock investing, here's how to buy Contrafect stock.

What is the 52 week high and low for Contrafect (NASDAQ: CFRX)?

(NASDAQ: CFRX) Contrafect's 52-week high was $4.54, and its 52-week low was $0.28. It is currently -93.83% from its 52-week high and 1.08% from its 52-week low.

How much is Contrafect stock worth today?

(NASDAQ: CFRX) Contrafect currently has 39,332,721 outstanding shares. With Contrafect stock trading at $0.28 per share, the total value of Contrafect stock (market capitalization) is $11.01M.

Contrafect stock was originally listed at a price of $52.10 in Sep 12, 2014. If you had invested in Contrafect stock at $52.10, your return over the last 7 years would have been -99.46%, for an annualized return of -52.6% (not including any dividends or dividend reinvestments).

How much is Contrafect's stock price per share?

(NASDAQ: CFRX) Contrafect stock price per share is $0.28 today (as of Aug 9, 2022).

What is Contrafect's Market Cap?

(NASDAQ: CFRX) Contrafect's market cap is $11.01M, as of Aug 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Contrafect's market cap is calculated by multiplying CFRX's current stock price of $0.28 by CFRX's total outstanding shares of 39,332,721.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.